Cargando…

A Practical Approach to Glucose Abnormalities in Cystic Fibrosis

Cystic fibrosis is a common genetic condition and abnormal glucose handling leading to cystic fibrosis-related diabetes (CFRD) is a frequent comorbidity. CFRD is mainly thought to be the result of progressive pancreatic damage resulting in beta cell dysfunction and loss of insulin secretion. Whilst...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jones, Gregory C., Sainsbury, Christopher A. R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118243/ https://www.ncbi.nlm.nih.gov/pubmed/27752941 http://dx.doi.org/10.1007/s13300-016-0205-8

Ejemplares similares

Patterns and Impact of Hypoglycemia, Hyperglycemia, and Glucose Variability on Inpatients with Insulin-Treated Cystic Fibrosis-Related Diabetes
por: Jones, Gregory C., et al.
Publicado: (2016)

Early Glucose Abnormalities in Cystic Fibrosis Are Preceded by Poor Weight Gain
por: Hameed, Shihab, et al.
Publicado: (2010)

Hepatic enzyme ALT as a marker of glucose abnormality in men with cystic fibrosis
por: Colomba, Johann, et al.
Publicado: (2019)

Dietary interventions for managing glucose abnormalities in cystic fibrosis: a systematic review protocol
por: Birch, Laura, et al.
Publicado: (2018)

A Practical Review of C-Peptide Testing in Diabetes
por: Leighton, Emma, et al.
Publicado: (2017)

The effect of cystic fibrosis transmembrane conductance regulator modulators on impaired glucose tolerance and cystic fibrosis related diabetes
por: Hasan, Sana, et al.
Publicado: (2022)

Impaired Fasting Glucose in Cystic Fibrosis
por: Frohnert, Brigitte I., et al.
Publicado: (2010)

Abnormal Unsaturated Fatty Acid Metabolism in Cystic Fibrosis: Biochemical Mechanisms and Clinical Implications
por: Seegmiller, Adam C.
Publicado: (2014)

Cell-Based Therapeutic Approaches for Cystic Fibrosis
por: Duchesneau, Pascal, et al.
Publicado: (2020)

Novel therapeutic approaches for the management of cystic fibrosis
por: Jaques, Ryan, et al.
Publicado: (2020)

Abnormal localization of cystic fibrosis transmembrane conductance regulator in primary cultures of cystic fibrosis airway epithelia
Publicado: (1992)

Practical Guidelines: Lung Transplantation in Patients with Cystic Fibrosis
por: Hirche, T. O., et al.
Publicado: (2014)

Is Cystic Fibrosis Lung Disease Caused by Abnormal Ion Composition or Abnormal Volume?
por: Krouse, Mauri E.
Publicado: (2001)

An inflammatory Signature of Glucose Impairment in Cystic Fibrosis
por: Montemari, Anna Lisa, et al.
Publicado: (2022)

Structural abnormalities in islets from very young children with cystic fibrosis may contribute to cystic fibrosis-related diabetes
por: Bogdani, Marika, et al.
Publicado: (2017)

Cystic Fibrosis
por: Dodge, J A
Publicado: (1997)

The Extrapulmonary Effects of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Cystic Fibrosis
por: Sergeev, Valentine, et al.
Publicado: (2020)

Cystic fibrosis: current therapeutic targets and future approaches
por: Rafeeq, Misbahuddin M., et al.
Publicado: (2017)

Approaches to Targeting Bacterial Biofilms in Cystic Fibrosis Airways
por: Martin, Isaac, et al.
Publicado: (2021)

Novel approaches to the treatment of Pseudomonas aeruginosa infections in cystic fibrosis
por: Hurley, Matthew N., et al.
Publicado: (2012)

Best practices in the treatment of early cystic fibrosis lung disease
por: Proesmans, Marijke
Publicado: (2016)

Managing Fungal Infections in Cystic Fibrosis Patients: Challenges in Clinical Practice
por: Magee, Lauren C, et al.
Publicado: (2021)

Role of vitamin D in cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Moustaki, Maria, et al.
Publicado: (2017)

Cystic Fibrosis
por: Gibson, Lewis E.
Publicado: (1969)

Exercise Training in Children and Adolescents with Cystic Fibrosis: Theory into Practice
por: Williams, Craig A., et al.
Publicado: (2010)

Abnormal pro-gly-pro pathway and airway neutrophilia in pediatric cystic fibrosis
por: Turnbull, Andrew R., et al.
Publicado: (2020)

Impaired glucose tolerance and indeterminate glycemia in cystic fibrosis
por: Kasim, Nader, et al.
Publicado: (2021)

Hypoglycemia in Adults With Cystic Fibrosis During Oral Glucose Tolerance Testing
por: Hirsch, Irl B., et al.
Publicado: (2013)

Strategies to optimize treatment adherence in adolescent patients with cystic fibrosis
por: Bishay, Lara C, et al.
Publicado: (2016)

Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives
por: Schmidt, Béla Z, et al.
Publicado: (2016)

Glucose Tolerance during Pulmonary Exacerbations in Children with Cystic Fibrosis
por: Widger, John, et al.
Publicado: (2012)

Current Practices and Potential Nanotechnology Perspectives for Pain Related to Cystic Fibrosis
por: Trandafir, Laura M., et al.
Publicado: (2019)

Lumacaftor/ivacaftor in cystic fibrosis: effects on glucose metabolism and insulin secretion
por: Colombo, C., et al.
Publicado: (2021)

Cystic fibrosis-related diabetes: optimizing care with a multidisciplinary approach
por: Frost, Freddy, et al.
Publicado: (2019)

Physiological Impact of Abnormal Lipoxin A(4) Production on Cystic Fibrosis Airway Epithelium and Therapeutic Potential
por: Higgins, Gerard, et al.
Publicado: (2015)

Bicarbonate Transport in Cystic Fibrosis and Pancreatitis
por: Angyal, Dora, et al.
Publicado: (2021)

When is cystic fibrosis not cystic fibrosis? The importance of appropriately classifying patients
por: Faro, Albert, et al.
Publicado: (2022)

The Resolution Approach to Cystic Fibrosis Inflammation
por: Recchiuti, Antonio, et al.
Publicado: (2020)

Porosome in Cystic Fibrosis
por: Jena, Bhanu P.
Publicado: (2014)

Aztreonam Lysine Inhalation Solution in Cystic Fibrosis
por: Elson, Elizabeth Claire, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_pg8h78hpmc30p8keub4vd7qvea